Fluid AI Medical's Origin Device Gains FDA Clearance for Postoperative Monitoring

Fluid AI Medical has received FDA 510(k) clearance for its Origin device, a real-time, bedside monitoring system for surgical effluent in postoperative settings, announced in a press release. The Origin system can function independently or integrate with Stream Care, the company's AI-assisted surgical suite.

The clearance marks a significant step for Fluid AI Medical, enabling the company to expand its market reach across North America, Europe, and the Middle East. The Origin device provides continuous monitoring, transforming intermittent measurements into real-time data, which can help clinicians detect subtle biochemical changes that may indicate recovery progress or potential complications.

While the Origin system is not yet intended to diagnose postoperative complications in the U.S., its continuous sensing capabilities contribute to Fluid AI Medical's predictive models, paving the way for more proactive patient care. The company is backed by strategic collaborations with government agencies and global healthcare providers, further supporting its mission to enhance postoperative recovery through data-driven insights.